van Bockel J H, van Schilfgaarde R, Felthuis W, Hermans J, van Brummelen P, Terpstra J L
Surgery. 1987 Jun;101(6):698-705.
This study evaluates the long-term efficacy of reconstructive surgery for renovascular hypertension caused by arteriosclerosis, which was performed on 112 patients from 1959 to 1983. Despite medical therapy, all patients had persistent hypertension, with a mean preoperative blood pressure of 188/113 mm Hg. Their median age was 49 years, and the median duration of objectively documented hypertension was 21 months at the time of surgery. Manifestations of extrarenal arteriosclerosis (ERA) were present in 57 patients (51%). Results were evaluated both at a short-term (ST) interval (mean: 8.4 months) and at a long-term (LT) interval (mean: 8.9 years) postoperatively. Patients were classified by means of strict criteria as cured, improved, or unsuccessfully treated. If a patient was cured or if his condition improved, this was considered a beneficial blood pressure response. Beneficial responses were maintained during LT follow-up, since the respective percentages for cure and improvement were 24% and 50% at the ST interval and 18% and 61% at the LT interval. These results had not been influenced by either older age or the presence of ERA, since results were similar in patients older and younger than the median age and in those with and without ERA. The preoperative duration of hypertension was the only pertinent clinical feature that influenced the LT interval results, LT beneficial responses were observed in 95% of the patients with a shorter duration and in 78% of those with a longer duration of preoperative hypertension than the median (p = 0.01). We conclude that surgical therapy for renovascular hypertension caused by arteriosclerosis can effectively reduce blood pressure and that this result is maintained during LT follow-up. In terms of anticipated blood pressure response, older age, longer duration of hypertension, and the presence of ERA do not exclude surgical therapy.
本研究评估了1959年至1983年期间对112例因动脉硬化所致肾血管性高血压患者进行重建手术的长期疗效。尽管进行了药物治疗,但所有患者仍持续高血压,术前平均血压为188/113 mmHg。他们的年龄中位数为49岁,手术时客观记录的高血压持续时间中位数为21个月。57例患者(51%)存在肾外动脉硬化(ERA)表现。术后分别在短期(ST)间隔(平均:8.4个月)和长期(LT)间隔(平均:8.9年)评估结果。根据严格标准将患者分为治愈、改善或治疗失败。如果患者治愈或病情改善,则认为是有益的血压反应。有益反应在长期随访中得以维持,因为在短期间隔时治愈和改善的相应百分比分别为24%和50%,在长期间隔时为18%和61%。这些结果未受年龄较大或ERA存在的影响,因为年龄大于和小于年龄中位数的患者以及有和没有ERA的患者结果相似。术前高血压持续时间是影响长期间隔结果的唯一相关临床特征,术前高血压持续时间短于中位数的患者中有95%观察到长期有益反应,而术前高血压持续时间长于中位数的患者中有78%观察到长期有益反应(p = 0.01)。我们得出结论,动脉硬化所致肾血管性高血压的手术治疗可有效降低血压,且该结果在长期随访中得以维持。就预期的血压反应而言,年龄较大、高血压持续时间较长以及ERA的存在并不排除手术治疗。